Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Recovery of New Agent from Patients with Acute Respiratory Illness
1954309 citationsJ. Werner et al.Experimental Biology and Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of J. Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Werner more than expected).
This network shows the impact of papers produced by J. Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Werner. The network helps show where J. Werner may publish in the future.
Co-authorship network of co-authors of J. Werner
This figure shows the co-authorship network connecting the top 25 collaborators of J. Werner.
A scholar is included among the top collaborators of J. Werner based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with J. Werner. J. Werner is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Werner, J., et al.. (1978). Serovaccination by human immune globulin and HDCS-vaccine against rabies.. PubMed. 40. 129–36.3 indexed citations
3.
Kuwert, E., O. Thraenhart, J. Werner, et al.. (1978). Comparative study on antibody determination by different methods in sera of persons vaccinated with HDCS rabies vaccine.. PubMed. 40. 221–9.5 indexed citations
4.
Werner, J., et al.. (1978). Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans.. PubMed. 40. 79–88.15 indexed citations
5.
Werner, J., et al.. (1977). [Immunogenicity, efficacy and reactogenicity of a human diploid cell strain (HDCS) rabies vaccine in man; recommendations for pre- and post-exposure application (vaccination scheme) (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(18). 797–805.3 indexed citations
Hilleman, M. R., et al.. (1958). Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients.. PubMed. 52(1). 53–7.2 indexed citations
Werner, J., et al.. (1954). Recovery of New Agent from Patients with Acute Respiratory Illness. Experimental Biology and Medicine. 85(1). 183–188.309 indexed citations breakdown →
Hilleman, M. R., J. Werner, & Ross L. Gauld. (1953). Influenza antibodies in the population of the USA; an epidemiological investigation.. PubMed. 8(5-6). 613–31.25 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.